Lonza Group AG, KKR and Capsugel S.A. have entered into a definitive agreement under which Lonza will acquire Capsugel from KKR for $5.5 billion in cash. The acquisition is part of Lonza’s strategy to grow its existing offerings and open up new market opportunities in the pharma and consumer healthcare and nutrition industries. Capsugel expands Lonza’s market reach and contract development and manufacturing products businesses.   The acquisition aims to integrate services in drug develop...